Nick Littlefield is named as a lobbyist on federal disclosure filings for 30 clients through Foley Hoag LLP. The most recent filing naming them posted in October 2013. Issues reported include Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs and Copyright/Patent/Trademark.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ELI LILLY AND COMPANY | FOLEY HOAG LLP | Q3 2013 | Copyright/Patent/Trademark, Health Issues |
| SANOFI US SERVICES INC | FOLEY HOAG LLP | Q3 2013 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark |
| CUBIST PHARMACEUTICALS | FOLEY HOAG LLP | Q3 2013 | Medicare/Medicaid, Health Issues |
| COALITION FOR THE 21ST CENTURY | FOLEY HOAG LLP | Q3 2013 | Medical/Disease Research/Clinical Labs, Health Issues |
| AMGEN | FOLEY HOAG LLP | Q3 2013 | Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues |
| GILEAD SCIENCES INC | FOLEY HOAG LLP | Q1 2013 | Medicare/Medicaid, Health Issues |
| AMERICAN COLLEGE OF GASTROENTEROLOGY | FOLEY HOAG LLP | Q1 2013 | Medicare/Medicaid, Health Issues |
| CHIMERIX, INC. | FOLEY HOAG LLP | Q4 2012 | Health Issues |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION | FOLEY HOAG LLP | Q4 2012 | Health Issues |
| ORGANOGENESIS INC. | FOLEY HOAG LLP | Q2 2012 | Medicare/Medicaid |
| TELADOC INC | FOLEY HOAG LLP | Q2 2012 | Health Issues |
| OPTIMER PHARMACEUTICALS, INC. | FOLEY HOAG LLP | Q2 2012 | Medicare/Medicaid |
| XDX INC | FOLEY HOAG LLP | Q1 2012 | Medicare/Medicaid |
| SUSAN G KOMEN FOR THE CURE | FOLEY HOAG LLP | Q1 2012 | Budget/Appropriations, Health Issues |
| STATE OF THE USA | FOLEY HOAG LLP | Q1 2012 | Government Issues |
| TETHYS BIOSCIENCE | FOLEY HOAG LLP | Q1 2009 | Medicare/Medicaid |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FOLEY HOAG LLP | Q2 2009 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark |
| PFIZER INC | FOLEY HOAG LLP | Q2 2009 | Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues |
| INVERNESS MEDICAL INNOVATIONS | FOLEY HOAG LLP | Q4 2009 | Health Issues |
| GENENTECH INC | FOLEY HOAG LLP | Q3 2009 | Medical/Disease Research/Clinical Labs, Health Issues |
| PARTNERS HEALTHCARE SYSTEM | FOLEY HOAG LLP | Q4 2011 | Medicare/Medicaid, Health Issues |
| DOVETAIL HEALTH | FOLEY HOAG LLP | Q4 2011 | Health Issues |
| ADVANCED CELL TECHNOLOGY | FOLEY HOAG LLP | Q3 2011 | Health Issues |
| ADAMAS PHARMACEUTICALS | FOLEY HOAG LLP | Q2 2010 | Health Issues |
| BRISTOL-MYERS SQUIBB | FOLEY HOAG LLP | Q1 2010 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark |
| EISAI CORPORATION OF NORTH AMERICA | FOLEY HOAG LLP | Q2 2009 | Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues |
| GLAXOSMITHKLINE | FOLEY HOAG LLP | Q4 2008 | Pharmacy |
| BIOGEN IDEC INC | FOLEY HOAG LLP | Q4 2008 | Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Health Issues |
| ASTRAZENECA PHARMACEUTICALS LP | FOLEY HOAG LLP | Q3 2008 | Medicare/Medicaid |
| SANOFI-AVENTIS U S INC | FOLEY HOAG LLP | Q1 2008 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2013 | 7 | 1 |
| 2012 | 14 | 1 |
| 2011 | 15 | 1 |
| 2010 | 18 | 1 |
| 2009 | 19 | 1 |
| 2008 | 17 | 1 |
| Year | Items | Total |
|---|---|---|
| 2013 | 2 | $1K |
| 2012 | 8 | $4K |
| 2011 | 13 | $8K |
| 2010 | 20 | $12K |
| 2009 | 11 | $10K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Nick Littlefield. See the Capitol Clarity rankings and method.